Publications

Search our bibliography using the filters on the right-hand side.

Displaying 401 through 450 of 7968 publications.

Cueto HT, Jacobsen BH, Laursen ASD, Riis AH, Hatch EE, Wise LA, Trolle E, Sorensen HT, Rothman KJ, Wesselink AK, Willis S, Johannesen BR, Mikkelsen EM. Dietary folate intake and fecundability in two preconception cohorts. Hum Reprod. 2022 Apr 1;37(4):828-37. doi: 10.1093/humrep/deac002.

Boucher N, Van Voorhees E, Vashi A, Dong O, Morgan P, Smith JE, Adam S, Alishahi A, Mulholland MJ, Dietch JR, Whited JD, Boggan JC, Fulton JJ, Cameron CB, Gordon A, Goldstein KM, Ear B, Williams JW, Cantrell S, Dickerson SW, Gierisch JM. Tele-urgent care for low-acuity conditions: a systematic review. 2022.

McKinnon CJ, Hatch EE, Orta OR, Rothman KJ, Eisenberg ML, Wefes-Potter J, Wise LA. The association between work hours, shift work, and job latitude with fecundability: a preconception cohort study. J Occup Health Psychol. 2022 Apr;27(2):258-65. doi: 10.1037/ocp0000279

Anderson-Smits C, Park M, Bell J, Mitchell S, Hartley L, Hawe E. Subcutaneous immunoglobulin use in immunoglobulin-naïve patients with primary immunodeficiency: a systematic review. Immunotherapy. 2022 Apr;14(5):373-87. doi: 10.2217/imt-2021-0265

Gnanasakthy A, Norcross L, (DeMuro) Romano C, Carson RT. A review of patient-reported outcome labeling of FDA-approved new drugs (2016-2020): counts, categories, and comprehensibility. Value Health. 2022 Apr;25(4):647-55. doi: 10.1016/j.jval.2021.10.006

Rivero-Ferrer E, Olesen M, Plana E, Aguado J, Saigi-Morgui N, Rubino A, Daoud SZ, Lei A, Perez-Gutthann S, Schink S, Kristiansen NS, Hallas J, Pottegard A, Rebordosa C. Characteristics of new users of aclidinium bromide, aclidinium/formoterol, and other COPD medications in the United Kingdom, Denmark, and Germany. Clin Drug Invest. 2022 Apr;42(4):319-31. doi: 10.1007/s40261-022-01120-2

Spira A, Liao L, Zhou X, Sherif B, Chen L, Ungar D, Yu E, Radford J, Hamadani M. Health-related quality of life, symptoms, and tolerability of Loncastuximab Tesirine in older versus younger patients with relapsed/refractory diffuse large b-cell lymphoma treated in a phase 2 clinical trial (LOTIS-2). Poster presented at the National Comprehensive Cancer Network (NCCN) 2022 Virtual Annual Conference; March 31, 2022.

Prabhu V, Kelkar S, Corman S, Macahilig C, Rusibamayila N, Odak S, Duska L. Treatment patterns, real-world outcomes, and resource use in patients with non-MSI-high or mismatch repair proficient advanced endometrial cancer. Poster presented at the 2022 Virtual Hem/Onc Pharmacists Assoc (HOPA) Annual Conference; March 30, 2022. Boston, MA.

Patel S, Vaccaro J, Garcia B, Schwab P, Ellis J. Disease characterization of herpes zoster (shingles) in a Medicare advantage population with and without vaccine administration. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL.

Anderson-Smits C, Orange J, Park M, Huang Z, Layton JB, Ritchey ME. Immunoglobulin initiation among patients with primary immunodeficiency diseases: a retrospective claims-based United States cohort study. Presented at the AMCP 2022 Meeting; March 29, 2022. Chicago, IL.

Qin S, McLeod L, Ma J, Cai J. Initial psychometric evaluation of the eczema symptom and impact diary in patients with moderate to severe atopic dermatitis from a phase 2 trial. Poster presented at the 2022 American Academy of Dermatology (AAD) Annual Meeting; March 25, 2022. Boston, MA.

Neumann M, Kakani S, Allen J, Ladner A, Rauen M, Weaver M, Mercer D. Transitioning in and transitioning out: parent and adult patient experiences with healthcare for intestinal failure. Poster presented at the 2022 ASPEN Nutrition Science & Practice Conference; March 22, 2022. Seattle, Washington.

Neumann M, Allen J, Kakani S, Ladner A, Rauen M, Weaver M, Mercer D. Beyond clinical outcomes: using a disease-specific pilot survey to explore parent perceptions of wellbeing for children with short bowel syndrome. Poster presented at the 2022 ASPEN Nutrition Science & Practice Conference; March 21, 2022. Seattle, Washington.

Clark M, Romano C, Olayinka-Amao O, Whalley D, Crawford R, Pathak P, Brindicci C, Garg K, Kordy K, Everhard F, Patalano F, Roesler Z, Sutton T, Goransson O, Landles R, Naujoks C, Marvel J, Keininger DL. Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary. J Patient Rep Outcomes. 2022 Mar 20;6(1):25. doi: 10.1186/s41687-022-00432-3

Forns J, Danysh H, McQuay L, Turner ME, Dempsey C, Anthony M, Layton B. Natural history of dementia-related psychosis and antipsychotic treatment patterns in older adults in the United States. Presented at the International Conference on Alzheimer's and Parkinson's Diseases 2022; March 18, 2022. Barcelona, Spain.

Martin S, Shah SN, Hepp Z, Harris N, Morgans AK. Qualitative analysis of pain in patients with locally advanced or metastatic urothelial carcinoma. Bladder Cancer. 2022 Mar 11;8(1):45-53. doi: 10.3233/BLC-211518

Guilbert E, Perry R, Whitmarsh A, Sauchelli S. Short-term effectiveness of nutrition therapy to treat type 2 diabetes in low-income and middle-income countries: systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2022 Mar 10;12(3):e056108. doi: 10.1136/bmjopen-2021-056108

Goyal RK, Zhang J, Dhuliawala S, Slug-O'Callaghan M, Kaufman PA. Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for metastatic breast cancer. Poster presented at the 39th Annual Miami Breast Cancer Conference; March 3, 2022. Miami Beach, FL.

Spelman T, Herring WL, Zhang Y, Tempest M, Pearson I, Freudensprung U, Acosta C, Dort T, Hyde R, Havrdova E, Horakova D, Trojano M, De Luca G, Lugaresi A, Izquierdo G, Grammond P, Duquette P, Alroughani R, Pucci E, Granella F, Lechner-Scott J, Sola P, Ferraro D, Grand’Maison F, Terzi M, Rozsa C, Boz C, Hupperts R, Van Pesch V, Oreja-Guevara C, van der Walt A, Jokubaitis VG, Kalincik T, Butzkueven H. Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in the United Kingdom. Pharmacoeconomics. 2022 Mar;40(3):323-39.

Tahami Monfared AA, Houghton K, Zhang Q, Mauskopf J, Alzheimer’s Disease Neuroimaging Initiative. Staging disease severity using the Alzheimer's disease composite score (ADCOMS): a retrospective data analysis. Neurol Ther. 2022 Mar;11(1):413-34. doi: 10.1007/s40120-022-00326-y

Stapleton A, Casas M, Garcia J, Garcia R, Sunyer J, Guerra S, Abellan A, Lavi I, Dobano C, Vidal M, Gascon M. Associations between pre- and postnatal exposure to air pollution and lung health in children and assessment of CC16 as a potential mediator. Environ Res. 2022 Mar;204(Pt A):111900. doi: 10.1016/j.envres.2021.111900

Spira A, Zhou X, Chen L, Gnanasakthy A, Wang L, Ungar D, Curiel R, Liao L, Radford J, Kahl B. Health-related quality of life, symptoms, and tolerability of Loncastuximab Tesirine in patients with relapsed or refractory diffuse large b-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):158-68. doi: 10.1016/j.clml.2021.09.001

Samsell B, Lothman K, Samsell EE, Ideishi RI. Parents' experiences of caring for a child with autism spectrum disorder in the United States: a systematic review and metasynthesis of qualitative evidence. Fam Syst Health. 2022 Mar;40(1):93-104. doi: 10.1037/fsh0000654

Flem E, Graham J, Yi Z, Wisloff T, Johnson KD. Cost and health impact analysis of herpes zoster vaccination in Norway. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):315-26. doi: 10.1080/14737167.2021.1973893

Chen YH, Farnham PG, Hicks KA, Sansom SL. Estimating the HIV effective reproduction number in the United States and evaluating HIV elimination strategies. J Public Health Manag Pract. 2022 Mar;28(2). doi: 10.1097/PHH.0000000000001397

Jacox LA, Bocklage C, Edwards T, Mihas P, Lin FC, Ko CC. Understanding technology adoption by orthodontists: a quantitative study. Am J Orthod Dentofacial Orthop. 2022 Mar;161(3):364-74. doi: 10.1016/j.ajodo.2020.08.024

Zografos L, Wolin D, Andrews E, Calingaert B, Balabanova Y, Horvat-Brocker A, Tarenz C, Suzart-Woischnik K. Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries. Expert Opin Drug Saf. 2022 Mar;21(3):435-46. doi: 10.1080/14740338.2022.1998451

Hu A, Kwon M, Chung L, Rastegar J, Stevens L, Schwab P. HIV prep adherence on incidence of HIV diagnosis in a national health plan population. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Alpert C, Rhodes C, Stevens L, Ellis JJ, Johnson S, Schwab P. Evaluation of pharmacist-led interventions for patients flagged for high morphine milligram equivalents (MME). Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S93.

Patel SM, Schwab P, Garcia B, Ellis JJ, Vaccaro J. Description of vaccination status and incidence of shingles. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Huang I, Schwab P, Wojcicki S, Poonawalla I, Ellis JJ, Racsa P. Febrile neutropenia risk and health care costs in members receiving low-risk antineoplastic regimens with and without granulocyte colony stimulating factor primary prophylaxis support. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Sanders C, Schwab P, Poonawalla I, Grebe L, Sassack K, Kennedy K, Vaccaro J, Ellis J. A real-world characterization of adverse drug events of Bruton tyrosine kinase inhibitors. Poster presented at the 2021 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 13, 2022. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a).

Bratlee-Whitaker E, Hill N, Mogle J, Do J. Personality moderates affective responses to daily memory lapses in middle-aged and older adults without cognitive impairment. Poster presented at the 2022 Virtual Scientific Meeting of the Society for Affective Science; March 2022.

Brazelton A, Yande S, Pope R, Johnson ML, Musher B, Trivedi MV. Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers. Ann Gastroenterol. 2022 Mar;35(2):182-6. doi: 10.20524/aog.2022.0688.

Strand V, Kaeley GS, Bergman MJ, Gladman DD, Coates LC, Sherif B, Hur P, Parikh B, Gilloteau I, Mease PJ. The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomized phase 3 trial. Lancet Rheumatol. 2022 Mar 1;4(3):e208-19.

Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Appl Health Econ Health Policy. 2022 Mar;20(2):213-21. doi: 10.1007/s40258-021-00704-x

Marinelli M, Carsin AE, Turner MC, Fernandez-Somoano A, Rodriguez-Dehli AC, Basterrechea M, Santa-Marina L, Iniguez C, Lopez-Espinosa MJ, Sunyer J, Julvez J. Maternal sleep duration and neonate birth weight: a population-based cohort study. Int J Gynaecol Obstet. 2022 Mar;156(3):494-501. doi: 10.1002/ijgo.13685

Layton JB, Forns J, Turner ME, Dempsey C, Bartsch JL, Anthony MS, Danysh HE, Ritchey ME, Demos G. Falls and fractures in patients with Parkinson's Disease–related psychosis treated with Pimavanserin vs atypical antipsychotics: a cohort study. Drugs Real World Outcomes. 2022 Mar;9(1):9-22. doi: 10.1007/s40801-021-00284-1

Auclair D, Mansfield C, Fiala MA, Chari A, Cole CE, Kaufman JL, Orloff GJ, Siegel DS, Zonder JA, Mange B, Yesil J, Dalal M, Mikhael JR. Preferences and priorities for relapsed multiple myeloma treatments among patients and caregivers in the United States. Patient Prefer Adherence. 2022 Mar 1;2022(16):573-85. doi: 10.2147/PPA.S345906

Jia X, Zhao Y, Carrico J, Brodtkorb T-H, Mendelsohn AM, Lowry S, Feldman S, Wu JJ, Armstrong AW. Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. J Dermatolog Trea. 2022 Mar;33(2):740-8. doi: 10.1080/09546634.2020.1773382

Armstrong MA, Raine-Bennett T, Reed SD, Gatz J, Getahun D, Schoendorf J, Postlethwaite D, Fassett MJ, Peipert JF, Saltus CW, Merchant M, Alabaster A, Zhou X, Ichikawa L, Shi JM, Chiu VY, Xie F, Hunter S, Wang J, Ritchey ME, Chillemi G, Im TM, Takhar HS, Pisa F, Asiimwe A, Anthony MS. Association of the timing of postpartum intrauterine device insertion and breastfeeding with risks of intrauterine device expulsion. JAMA Netw Open. 2022 Feb 28;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474

Herrera-Restrepo O, Ghaswalla P, Davis K, Sweeney C, Davenport E, Andani A, Buck PO. What can Europe learn from HCP knowledge and attitudes towards hepatitis A vaccination in the US? Poster presented at the Virtual 2022 EASLViral Hepatitis Elimination Conference; February 24, 2022. Previously presented at the 14th European Public Health Virtual Conference 2021 (EPH).

Ainsworth C, Higuchi K, Simou E, Guyot P, Greene N. Relative differences in brain volume loss with teriflunomide versus other disease-modifying therapies in relapsing multiple sclerosis: a systematic review and network meta-analysis. Poster presented at the ACTRIMS Forum 2022; February 24, 2022. West Palm Beach, FL.

Zhou X, Davenport E, Ouyang J, Hoke ME, Garbinsky D, Agarwal I, Krasa HB, Oberdhan D. Pooled data analysis of the long-term treatment effects of tolvaptan in ADPKD. Kidney Int Rep. 2022 Feb 19;7(5):1037-48. doi: 10.1016/j.ekir.2022.02.009

Masterson D, Triguero-Mas M, Marquez S, Zijlema W, Martinez D, Gidlow C, Smith G, Hurst G, Cirach M, Grazuleviciene R, Van den Berg M, Kruize H, Maas J, Nieuwenhuijsen M. Use of the natural outdoor environment in different populations in Europe in relation to access: implications for policy. Int J Environ Res Public Health. 2022 Feb 16;19(4):2226. doi: 10.3390/ijerph19042226

Ghaswalla P, Davis K, Sweeney C, Davenport E, Trofa A, Herrera-Restrepo O, Buck PO. Health care providers' knowledge, practices, and barriers to hepatitis vaccination guidelines. J Nurse Pract. 2022 Feb 16;18:403-10.

Danese S, Kamble P, Yang J, Le Moine JG, Khan S, Hawe E, Agboton C, Wang S, Irving PM. Systematic literature review and meta-analysis: real-world mucosal healing in Vedolizumab-treated patients with Crohn's disease. GastroHep. 2022 Feb 16. doi: 10.1155/2022/6975416

Law EH, Galve-Calvo E, Wockel A, Parikh R, Kurosky SK, Derrien Ansquer V, Frugier G, Davis KL, Esterberg E, Oikonomidou O. European treatment patterns and outcomes associated with first-line CDK4/6 inhibition and hormonal therapies assessed in a real-world non-interventional study (EUCHARIS). Poster presented at the 2021 San Antonio Breast Cancer Symposium (SABCS); December 7, 2021. San Antonio, TX. [abstract] Cancer Res. 2022 Feb 15; 82(4_Suppl):OT2-19-04. doi: 10.1158/1538-7445.SABCS21-OT2-19-04

Power JEM, Feeney J, Fowler E, McMichael AJ, Hyland P, Lawlor BA, Cruise S, Potter C, Young I, McGuinness B, Kee F. Exposure to the troubles in Northern Ireland, memory functioning, and social activity engagement: results from NICOLA. Eur J Ageing. 2022 Feb 10. doi: 10.1007/s10433-022-00683-5

Yee KS, Alexanderian D, Hamm L, Martin S, Olayinka-Amao B, Whiteman DAH. Clinical investigator perspectives on the effects of intrathecal idursulfase-IT treatment in children with neuronopathic mucopolysaccharidosis type II. Poster presented at the 2022 18th Annual World Symposium; February 7, 2022. San Diego, CA.